中国医疗保险
中國醫療保險
중국의료보험
CHINA HEALTH INSURANCE
2013年
1期
40-42
,共3页
医药分业%药品市场%医疗保险%影响分析
醫藥分業%藥品市場%醫療保險%影響分析
의약분업%약품시장%의료보험%영향분석
separation of dispensing from prescription%medicine market%medical insurance%policy analysis
医药分业和医药合一各有利弊,西方国家的医药分业是一个自然演进过程,而东方国家多为医药合一体系,为解决药品过度和不合理使用问题,韩国、日本等国进行了医药分业改革,但效果并不好.我国对医药分业的讨论由来已久,近来因公立医院改革而再度被关注.从公共改革目标出发,考察医药分业的利益格局调整及影响,政府主导下的医药分业改革应当审慎.
醫藥分業和醫藥閤一各有利弊,西方國傢的醫藥分業是一箇自然縯進過程,而東方國傢多為醫藥閤一體繫,為解決藥品過度和不閤理使用問題,韓國、日本等國進行瞭醫藥分業改革,但效果併不好.我國對醫藥分業的討論由來已久,近來因公立醫院改革而再度被關註.從公共改革目標齣髮,攷察醫藥分業的利益格跼調整及影響,政府主導下的醫藥分業改革應噹審慎.
의약분업화의약합일각유리폐,서방국가적의약분업시일개자연연진과정,이동방국가다위의약합일체계,위해결약품과도화불합리사용문제,한국、일본등국진행료의약분업개혁,단효과병불호.아국대의약분업적토론유래이구,근래인공립의원개혁이재도피관주.종공공개혁목표출발,고찰의약분업적이익격국조정급영향,정부주도하적의약분업개혁응당심신.
There are pros and cons to separate medicine from medical. Separation between medicine and medical is nature process in western countries. As a reform process in eastern countries, It is aim to resolve overuse and abuse of drug. The result was not satisfactory in Korea, Japan et al. it has been discussed for long period in China. The effectiveness in public management and benefit modulation was discussed in this paper. The author suggested that government should be careful to separated medicine from medical in China.
